loading

Anixa Biosciences Inc Borsa (ANIX) Ultime notizie

pulisher
Dec 12, 2025

D. Boral Capital Maintains Anixa Biosciences (ANIX) Buy Recommendation - Nasdaq

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences (ANIX) Shares Drop 21% After Phase 1 Vaccine D - GuruFocus

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences falls on phase 1 data for breast cancer vaccine - Seeking Alpha

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences (NASDAQ:ANIX) Given "Buy" Rating at D. Boral Capital - MarketBeat

Dec 12, 2025
pulisher
Dec 12, 2025

ANIX: D. Boral Capital Maintains Buy Rating with $10 Price Targe - GuruFocus

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences Reports Positive Phase 1 Trial Results - TipRanks

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences Inc Announces Positive Phase 1 Data for Breast Cancer Vaccine - TradingView

Dec 12, 2025
pulisher
Dec 12, 2025

Anixa Biosciences Says Breast Cancer Vaccine Candidate Meets Key Endpoints in Phase 1 Trial - marketscreener.com

Dec 12, 2025
pulisher
Dec 11, 2025

Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cance - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Anixa Biosciences (ANIX) Presents Promising Phase 1 Breast Cancer Vaccine Results - GuruFocus

Dec 11, 2025
pulisher
Dec 11, 2025

Anixa’s breast cancer vaccine shows positive Phase 1 results - Investing.com

Dec 11, 2025
pulisher
Dec 11, 2025

Anixa Biosciences Announces Positive Phase 1 Data for Investigational Breast Cancer Vaccine; Primary Endpoints Were Met and Immune Response Observed in 74% of Participants - PR Newswire

Dec 11, 2025
pulisher
Dec 11, 2025

Anixa Biosciences Inc (NASDAQ:ANIX) Given Average Rating of "Hold" by Brokerages - MarketBeat

Dec 11, 2025
pulisher
Dec 10, 2025

Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Monday, December 15, 2025 - PR Newswire

Dec 10, 2025
pulisher
Dec 10, 2025

Anixa Biosciences (NASDAQ: ANIX) sets Dec. 15 talk on Phase 1 breast cancer vaccine - Stock Titan

Dec 10, 2025
pulisher
Dec 09, 2025

Anixa Biosciences (NASDAQ: ANIX) unveils final Phase 1 breast cancer vaccine results at 2025 SABCS - Stock Titan

Dec 09, 2025
pulisher
Dec 05, 2025

Will Anixa Biosciences Inc. (CY71) stock beat Nasdaq index returns2025 Risk Factors & Real-Time Stock Entry Alerts - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why Anixa Biosciences Inc. (CY71) stock is trending on social mediaPortfolio Update Report & Fast Momentum Stock Entry Tips - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Will Anixa Biosciences Inc. stock see PE expansionWeekly Trading Summary & Risk Controlled Stock Pick Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Is Anixa Biosciences Inc. stock undervalued vs historical averagesJuly 2025 WrapUp & Free Technical Pattern Based Buy Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Who are in the management team of Anixa Biosciences, Inc.? - Markets Mojo

Dec 04, 2025
pulisher
Dec 04, 2025

Is Anixa Biosciences Inc. stock a bargain at current levelsJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How risky is Anixa Biosciences Inc. (CY71) stock compared to peersLayoff News & Accurate Intraday Trading Signals - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Can Anixa Biosciences Inc. (CY71) stock sustain double digit ROEJuly 2025 Action & Stepwise Trade Signal Implementation - Newser

Dec 04, 2025
pulisher
Dec 03, 2025

How Anixa Biosciences Inc. stock compares to growth peersJuly 2025 Catalysts & Risk Adjusted Buy/Sell Alerts - Newser

Dec 03, 2025
pulisher
Dec 02, 2025

Anixa Biosciences (ANIX) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025
pulisher
Nov 29, 2025

Why retail investors pile into Anixa Biosciences Inc. stock2025 Institutional Moves & High Accuracy Trade Alerts - moha.gov.vn

Nov 29, 2025
pulisher
Nov 28, 2025

Anixa Biosciences Announces Completion of Final Patient Visit in Breast Cancer Vaccine Clinical Trial (PR Newswire) - Aktiellt

Nov 28, 2025
pulisher
Nov 27, 2025

Can Anixa Biosciences Inc. stock attract ESG capital inflows2025 Top Decliners & Low Risk High Win Rate Stock Picks - moha.gov.vn

Nov 27, 2025
pulisher
Nov 22, 2025

Anixa Biosciences Announces World Health Organization (WHO) Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization - Quantisnow

Nov 22, 2025
pulisher
Nov 21, 2025

Anixa Biosciences (NASDAQ:ANIX) Stock Rating Lowered by Zacks Research - MarketBeat

Nov 21, 2025
pulisher
Nov 21, 2025

Is Anixa Biosciences Inc. stock a top momentum playGold Moves & Precise Entry and Exit Recommendations - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

How geopolitical risks impact Anixa Biosciences Inc. (CY71) stockWeekly Trade Recap & High Return Trade Guides - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Why Anixa Biosciences Inc. stock is recommended by analysts2025 Risk Factors & Long-Term Growth Portfolio Plans - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Anixa Biosciences (ANIX) Price Target Increased by 11.11% to 10.20 - MSN

Nov 20, 2025
pulisher
Nov 19, 2025

Intraday pattern recognizer results for Anixa Biosciences Inc.July 2025 EndofMonth & Reliable Price Breakout Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Anixa Biosciences Inc. stock prediction for this week2025 Bull vs Bear & Daily Volume Surge Signals - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Can Anixa Biosciences Inc. (CY71) stock resist broad market declinesPortfolio Value Summary & Real-Time Stock Entry Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Will Anixa Biosciences Inc. stock benefit from commodity pricesWeekly Trend Recap & Consistent Profit Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Backtesting results for Anixa Biosciences Inc. trading strategies2025 Key Lessons & Breakout Confirmation Alerts - newser.com

Nov 19, 2025
$38.39
price down icon 1.08%
$95.41
price down icon 0.72%
$31.31
price down icon 3.07%
$94.81
price down icon 1.24%
biotechnology ONC
$319.06
price down icon 0.55%
$197.01
price up icon 0.91%
Capitalizzazione:     |  Volume (24 ore):